21/12/2014 12:13:37 Free Membership Login

   

Achillion Pharmaceuticals, Inc.

Visual Financials
Company Name: Achillion Pharmaceuticals, Inc.
Ticker Symbol: ACHN
WWW Address: http://www.achillion.com
CEO: Milind Deshpande
No. of Employees: 57
Common Issue Type: CS
Business Description:Achillion Pharmaceuticals, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative treatments for infectious diseases.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 14.195 Down -0.35 14.21 14.2 14.36 14.54 13.90 6566041
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 1,423.0 100.2 0.00 -0.63 0.00 0.0 0.0 15.31 - 2.45
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close14.21$
PE Ratio - LTM0.0
Market Capitalisation1,423.0mil
Latest Shares Outstanding100.2mil
Earnings pS (EPS)-0.63$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float56.4mil
Float as % of Shares Outstanding0.6%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.00%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Assets Turnover0.0%
Return on Assets (ROA)-48.3%
Return on Equity (ROE)-52.4%
Return on Capital Invested (ROCI)-52.1%
Current Ratio13.3
Leverage Ratio (Assets/Equity)1.1
Interest Cover-1132.6
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Total Capital0.0%
Working Capital pS1.15$
Cash pS0.00$
Book-Value pS1.19$
Tangible Book-Value pS1.53$
Cash Flow pS-0.55$
Free Cash Flow pS-0.55$
KEY FIGURES (LTM): Price info
Price/Book Ratio11.90
Price/Tangible Book Ratio0.00
Price/Cash Flow-26.0
Price/Free Cash Flow-25.7
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---15.313.4634210
4 Weeks14.5413.9013.9015.313.461427
13 Weeks14.2114.21654389612.0515.311427
26 Weeks654389615.3115.3112.9115.311413
52 Weeks12.0512.0513.1615.312.451213
YTD2.452.45-15.312.456365
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
9.329.3211.5011.5015.310.650.65
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue870321005317367453173674
Income8703210087032100363078690
Dividend363078690742466418742466418
Capital Spending1197764544NA1197764544
R&D71200129NA71200129
Normalized Inc.363078690NA363078690
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %74309309
Earnings %350350329
EPS %108108108
EPS $3299797
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio162417000
Quick Ratio (Acid Test)37635000
Liquidity Ratio (Cash)0.00
Receivables Turnover
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS152958000
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)4591000
Debt Ratio9459000
Total Debt/Equity (Gearing Ratio)No
LT Debt/Equity
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities9459000
Interest Cover-5435000
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM756,923,961.00
Enterprise Value (EV)/EBITDA0.00
Enterprise Value (EV)/Free Cash Flow-76.78
Dividend Yield23232232
Price/Tangible Book Ratio - LTM139
Price/Book Ratio - LTM4741069
Price/Cash Flow Ratio13.3
Price/Free Cash Flow Ratio - LTM139
Price/Sales Ratio17.00
P/E Ratio (1 month ago) - LTM756923961
P/E Ratio (26 weeks ago) - LTM1073315601
P/E Ratio (52 weeks ago) - LTM1073315601
5-Y High P/E Ratio1199490691
5-Y Low P/E Ratio1183629235
5-Y Average P/E Ratio4691807
Current P/E Ratio as % of 5-Y Average P/E4691807
P/E as % of Industry Group4,351,605.0
P/E as % of Sector Segment4,351,605.0
Current 12 Month Normalized P/E Ratio - LTM4,833,970.0
PER SHARE FIGURES
LT Debt pS
Current Liabilities pS
Tangible Book Value pS - LTM13.3
Book Value pS - LTM4741069
Capital Invested pS0.00
Cash pS - LTM26271
Cash Flow pS - LTM3.45
Free Cash Flow pS - LTM3.45
Earnings pS (EPS)-79
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-5435000
Net Profit Margin - 5YEAR AVRG.2014-11-01
Equity Productivity0.00
Return on Equity (ROE)152958000
Return on Equity (ROE) - 5YEAR AVRG.1424512569
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.-100
Assets Productivity4,591,000.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.1424512569
Gross Profit Margin4351605
Gross Profit Margin - 5YEAR AVRG.-100
EBITDA Margin - LTM5585826
EBIT Margin - LTM4351605
Pre-Tax Profit Margin1265000
Pre-Tax Profit Margin - 5YEAR AVRG.100247190
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle9,403,571
Revenue per Employee
Net Income per Employee
Average Collection Period
Receivables Turnover
Day's Inventory Turnover Ratio9403000
Inventory Turnover
Inventory/Sales
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover4591000
Revenue per $ Cash4521000
Revenue per $ Plant4521000
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.100247190
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq achn141221 12:13